- Home
- SSYS vs AUTL Comparison
SSYS vs AUTL Comparison
Compare SSYS & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSYS
- AUTL
- Stock Information
- Founded
- SSYS 1989
- AUTL 2014
- Country
- SSYS United States
- AUTL United Kingdom
- Employees
- SSYS N/A
- AUTL N/A
- Industry
- SSYS Computer peripheral equipment
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SSYS Technology
- AUTL Health Care
- Exchange
- SSYS Nasdaq
- AUTL Nasdaq
- Market Cap
- SSYS 634.6M
- AUTL 590.8M
- IPO Year
- SSYS 1994
- AUTL 2018
- Fundamental
- Price
- SSYS $12.47
- AUTL $2.16
- Analyst Decision
- SSYS Strong Buy
- AUTL Strong Buy
- Analyst Count
- SSYS 4
- AUTL 3
- Target Price
- SSYS $11.50
- AUTL $10.20
- AVG Volume (30 Days)
- SSYS 668.2K
- AUTL 1.1M
- Earning Date
- SSYS 03-05-2025
- AUTL 03-13-2025
- Dividend Yield
- SSYS N/A
- AUTL N/A
- EPS Growth
- SSYS N/A
- AUTL N/A
- EPS
- SSYS N/A
- AUTL N/A
- Revenue
- SSYS $578,436,000.00
- AUTL $10,091,000.00
- Revenue This Year
- SSYS N/A
- AUTL $851.83
- Revenue Next Year
- SSYS $3.22
- AUTL $224.65
- P/E Ratio
- SSYS N/A
- AUTL N/A
- Revenue Growth
- SSYS N/A
- AUTL 82.71
- 52 Week Low
- SSYS $6.05
- AUTL $2.07
- 52 Week High
- SSYS $13.98
- AUTL $7.37
- Technical
- Relative Strength Index (RSI)
- SSYS 76.57
- AUTL 41.40
- Support Level
- SSYS $9.17
- AUTL $2.07
- Resistance Level
- SSYS $9.91
- AUTL $2.26
- Average True Range (ATR)
- SSYS 0.54
- AUTL 0.12
- MACD
- SSYS 0.28
- AUTL 0.01
- Stochastic Oscillator
- SSYS 98.44
- AUTL 25.00
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.